XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share Available to Common Stockholders (Tables)
9 Months Ended
Sep. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted net Income (Loss) Per Common Share
(in thousands, except share and per share amounts)Three Months Ended Nine Months Ended
September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Numerator:
Net loss available to common stockholders$(26,576)$(70,492)$(115,416)$(183,034)
Net loss available to common stockholders—basic(26,576)(70,492)(115,416)(183,034)
Denominator:
Weighted average common shares outstanding—basic65,060,729 64,398,448 64,880,008 64,210,809 
Dilutive effect of shares issuable under stock options— — — — 
Dilutive effect of RSUs— — — — 
Dilutive effect of PSUs— — — — 
Dilutive effect of Notes, if converted(1)
— — — — 
Weighted average common shares outstanding—diluted65,060,729 64,398,448 64,880,008 64,210,809 
Net loss per share available to common stockholders—basic and diluted$(0.41)$(1.09)$(1.78)$(2.85)
__________
(1) As the Company recorded a net loss in the three and nine months ended September 28, 2024 and September 30, 2023, inclusion of shares from the conversion premium or spread would be anti-dilutive. The Company had $1.15 billion in Notes outstanding as of September 28, 2024 and September 30, 2023.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following shares of common stock equivalents were excluded from the computation of diluted net loss per share available to common stockholders for the periods presented because the impact of including them would have been antidilutive:
Three Months EndedNine Months Ended
September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Options to purchase common stock5,406,662 4,383,626 5,406,662 4,383,626 
RSUs2,400,113 1,399,909 2,400,113 1,399,909 
PSUs225,967 — 225,967 — 
Total8,032,742 5,783,535 8,032,742 5,783,535